CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Planned sale Director sold 1,406 shares at an average $26.87 ($37,780)
- 4 Planned sale Director sold 1,406 shares at an average $26.91 ($37,834)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Financial Officer sold 4,982 shares at an average $21.69 ($108,076)
- 4 Planned sale Chief Financial Officer sold 15,018 shares at an average $20.76 ($311,806)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Financial Officer sold 9,900 shares at $21.13 ($209,151)
- 4 Planned sale Chief Commercial Officer sold 18,229 shares at an average $20.34 ($370,837)
- 4 Planned sale Chief Financial Officer sold 100 shares at $21.00 ($2,100)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 8 of 15 · 290 filings